1. Home
  2. RSLS vs SHFS Comparison

RSLS vs SHFS Comparison

Compare RSLS & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RSLS
  • SHFS
  • Stock Information
  • Founded
  • RSLS 2002
  • SHFS 2015
  • Country
  • RSLS United States
  • SHFS United States
  • Employees
  • RSLS N/A
  • SHFS N/A
  • Industry
  • RSLS Medical/Dental Instruments
  • SHFS Finance: Consumer Services
  • Sector
  • RSLS Health Care
  • SHFS Finance
  • Exchange
  • RSLS Nasdaq
  • SHFS Nasdaq
  • Market Cap
  • RSLS 5.7M
  • SHFS 6.3M
  • IPO Year
  • RSLS 2007
  • SHFS N/A
  • Fundamental
  • Price
  • RSLS $2.58
  • SHFS $2.46
  • Analyst Decision
  • RSLS
  • SHFS
  • Analyst Count
  • RSLS 0
  • SHFS 0
  • Target Price
  • RSLS N/A
  • SHFS N/A
  • AVG Volume (30 Days)
  • RSLS 458.6K
  • SHFS 47.4K
  • Earning Date
  • RSLS 08-18-2025
  • SHFS 08-13-2025
  • Dividend Yield
  • RSLS N/A
  • SHFS N/A
  • EPS Growth
  • RSLS N/A
  • SHFS N/A
  • EPS
  • RSLS N/A
  • SHFS N/A
  • Revenue
  • RSLS $7,175,000.00
  • SHFS $13,956,453.00
  • Revenue This Year
  • RSLS $52.80
  • SHFS N/A
  • Revenue Next Year
  • RSLS N/A
  • SHFS N/A
  • P/E Ratio
  • RSLS N/A
  • SHFS N/A
  • Revenue Growth
  • RSLS N/A
  • SHFS N/A
  • 52 Week Low
  • RSLS $2.23
  • SHFS $1.84
  • 52 Week High
  • RSLS $303.25
  • SHFS $13.80
  • Technical
  • Relative Strength Index (RSI)
  • RSLS 45.22
  • SHFS 39.43
  • Support Level
  • RSLS $2.35
  • SHFS $2.21
  • Resistance Level
  • RSLS $2.56
  • SHFS $2.96
  • Average True Range (ATR)
  • RSLS 0.25
  • SHFS 0.34
  • MACD
  • RSLS 0.05
  • SHFS -0.11
  • Stochastic Oscillator
  • RSLS 21.77
  • SHFS 21.04

About RSLS ReShape Lifesciences Inc.

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

Share on Social Networks: